Pepticom Competitors and Similar CompaniesClear all

Pepticom's competitors and similar companies include Wren Therapeutics, Digi-Prex, STADA and Apeloa Pharmaceutical.

	Pepticom Pepticom is a company that develops computational drugs from protein peptides.	Wren Therapeutics Wren Therapeutics is a biopharmaceutical company, which is focused on drug discovery and development for protein misfolding diseases.	Digi-Prex Digi-Prex is a chronic disease management platform that provides a holistic solution to assist in the care of patients with chronic diseases.	STADA STADA Arzneimittel is a company engaged in the healthcare and pharmaceuticals business.	Apeloa Pharmaceutical Apeloa Pharmaceutical (普洛药业股份有限公司) is a company that develops and produces pharmaceutical products.
Founding Date	Founding Date 2011	Founding Date 2016	Founding Date 2019	Founding Date 1895	Founding Date 1989
Type	Type Private	Type Private	Type Private	Type Public	Type Public
Tags	Tags Healthcare Technology artificial intelligence drug development healthtech pharma	Tags Healthcare Technology biotech drug development healthtech pharma	Tags Healthcare Technology drug development healthtech pharma platform	Tags Healthcare drug development healthtech pharma	Tags Healthcare drug development healthtech pharma
Locations	Locations Jerusalem, IL HQ	Locations Cambridge, GB HQ Lund, SE Cambridge, GB Cambridge, US	Locations HQ	Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more	Locations CN HQ
Employees	Employees 15	Employees 138% increase	Employees 27	Employees 12,33911% increase	Employees 7,060
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 6 b	Valuation ($) 2.7 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €3b (FY, 2020)	Revenue (est.) ¥9.7b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods €1.3b (FY, 2020)	Cost of goods ¥7.2b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit €1.7b (FY, 2020)	Gross profit ¥2.5b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income €181.9m (FY, 2020)	Net income ¥890.7m (FY, 2025)
Funding
Latest funding round	Latest funding round $ 5m (over 6 years ago)	Latest funding round $ 23.3m (over 7 years ago)	Latest funding round $ 5.5m (over 6 years ago)	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 5m	Total funding raised $ 23.3m	Total funding raised $ 5.7m	Total funding raised N/A	Total funding raised N/A